Linda Crnic Institute for Down Syndrome
Welcome,         Profile    Billing    Logout  
 4 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Norris, David
NCT04246372: Tofacitinib for Immune Skin Conditions in Down Syndrome

Active, not recruiting
2
47
US
Tofacitinib, Xeljanz
University of Colorado, Denver, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema, Hidradenitis Suppurativa, Vitiligo, Psoriasis
10/24
12/24
Espinosa, Joaquin
NCT04246372: Tofacitinib for Immune Skin Conditions in Down Syndrome

Active, not recruiting
2
47
US
Tofacitinib, Xeljanz
University of Colorado, Denver, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Down Syndrome, Alopecia Areata, Atopic Dermatitis / Eczema, Hidradenitis Suppurativa, Vitiligo, Psoriasis
10/24
12/24
NCT05662228: Therapies for Down Syndrome Regression Disorder

Recruiting
2
66
US
Lorazepam, Ativan, Intravenous immunoglobulin (IVIG), Gammagard Liquid (immune globulin infusion [human] 10%), Tofacitinib, Xeljanz
University of Colorado, Denver, Children's Hospital Los Angeles
Down Syndrome, Regression
12/26
12/26
TRC-DS, NCT04165109: Trial-Ready Cohort-Down Syndrome

Recruiting
N/A
450
Europe, US
Flutafuranol, [18F]NAV4694, NAV4694, Pittsburgh Compound (PIB), [11C]-PIB, PIB, MK6240, [18F]MK-6240
University of Southern California, National Institute on Aging (NIA), Alzheimer's Clinical Trials Consortium, Alzheimer's Therapeutic Research Institute
Down Syndrome, Alzheimer Disease, Dementia
12/25
12/25
NCT02864108: The Crnic Institute Human Trisome Project Biobank

Recruiting
N/A
2500
US
University of Colorado, Denver, Linda Crnic Institute for Down Syndrome, National Center for Advancing Translational Sciences (NCATS), GLOBAL Down Syndrome Foundation, Anna and John J. Sie Foundation
Down Syndrome, Trisomy 21
07/36
07/36

Download Options